Medical/Pharmaceuticals
Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378
* COPD study initiation expands SKB378/WIN378 development into a second major respiratory disease * SKB378/WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase 2 data expected in the second half of 2026 * SKB378/WIN378 has the potential to be the firs...
2026-06-09 20:18
3732
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development
* SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention * SK bioscience is jointly investing with the RIGHT Foundation to drive process development that enhances both efficacy and productivity * "We are committed to improving public health through...
2026-06-09 20:00
2698
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis
* Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. * Unique whole-cell design eliminates cell teardown, reducing sample preparation time by >90%. * Industry-leading Coin Cell DSC temperature range from –80...
2026-06-09 20:00
3385
Renowned Urologist Dr. (Col) Rajeev Sood joins Manipal Hospital Gurugram to strengthen Comprehensive Urology and Kidney Transplant services
GURUGRAM, India, June 9, 2026 /PRNewswire/ -- Manipal Hospital Gurugram, one of India's leading multi-specialty healthcare institutions, has further strengthened its Department of Urology, Robotics & Renal Transplant with the onboarding ofDr. (Col) Rajeev Sood, Chairman – Urology, Robotics & Rena...
2026-06-09 14:41
3650
GEHPA-APAC Alliance Officially Launched to Advance Inclusive & Intelligent Education and Healthcare
SHENZHEN, China, June 9, 2026 /PRNewswire/ -- Under the theme "Together, Advancing Inclusive & Intelligent Education and Healthcare," Huawei successfully hosted theHuawei APAC Education & Healthcare Partners Summit 2026 on June 5 as part of the 2026 Global Education & Healthcare Partners China C...
2026-06-09 14:06
3985
Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel
SHANGHAI, June 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an exclusive ...
2026-06-09 08:21
4207
THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE
Backed by direct scientific research with elite collegiate and youth athletes, CryoTherm Palm's cooling technology made its debut with the England national team supporting training camps, pre-tournament friendlies, and sideline recovery protocols LOS ANGELES, June 8, 2026 /PRNewswire/ -- Therabo...
2026-06-08 20:05
4185
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
* Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks. * Delivers up to 2x increase in resolving power and sensitivity to identify and track low-level impurities for improved regulatory read...
2026-06-08 20:00
4077
Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey
HANGZHOU, China, June 8, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190; "Zylox-Tonbridge" or the "Company"), a Hong Kong-listed medical technology company focused on neurovascular and peripheral vascular interventional products and solutions, announced that it has ...
2026-06-08 18:19
3023
2026 ADA | Innovent Presents Multiple Clinical and Preclinical Results of Next-Generation Obesity & Metabolic Pipeline
SAN FRANCISCO and SUZHOU, China, June 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
2026-06-08 16:30
4268
WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards
DUNDALK, Ireland, June 8, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that its Ireland site won the "Overall Excellence in Life Sciences" award, the highest recognition at the 2026 Life Scie...
2026-06-08 16:09
2720
Classico Pokemon Collection: "Stay with Your Favorite Pokemon Everywhere"
TOKYO, June 8, 2026 /PRNewswire/ -- Classico, Inc., a Japanese medical apparel brand headquartered in Tokyo, launched the highly anticipated #ClassicoPokemonCollection across the Asian region, including Singapore, Malaysia, the Philippines, Hong Kong SAR, Taiwan region and Thailand, on June 4. F...
2026-06-08 14:00
3253
Dong Bang Co Ltd Strengthens Global Competitiveness with Advanced Veterinary Pharmaceuticals
SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dong Bang Co Ltd is strengthening its position in the global veterinary pharmaceutical market with high-value products including pet anesthetics and livestock reproductive hormones. Since its establishment in 1983, the company has specialized in m...
2026-06-08 13:00
2549
Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)
SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positive topline results from its Phase II randomized, double-blind, placebo-controlled trial of CG2001 ...
2026-06-08 09:28
4289
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China
SHANGHAI, June 8, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an Asset Pur...
2026-06-08 08:55
6994
Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program
SAN DIEGO, June 8, 2026 /PRNewswire/ -- Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global Clinical Trials (GCT) as the lead contract research organization supporting international execution...
2026-06-08 08:30
2799
Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39
HONG KONG, June 8, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the presentation of three key studies at the American Diabetes Association (ADA) 2026 Scientific Sessions (taking place June 5-8, 2026, in New Orleans, Louisiana), highlighting its differentiated portf...
2026-06-08 08:10
3036
OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
SHANGHAI, June 7, 2026 /PRNewswire/ -- OriCell Therapeutics Holdings Limited ( The "Company" or "Oricell") ,announced that its proprietary GPC3-targeted autologous CAR-T therapy, Ori-C101, has received clearance from China's National Medical Products Administration (NMPA) to proceed into a confir...
2026-06-08 08:08
3277
Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
SHANGHAI and HONG KONG, June 8, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune di...
2026-06-08 08:00
3154
Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
NEW ORLEANS, June 8, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative therapies for metabolic diseases, today announced that key data from a head-to-head study (SLIMM...
2026-06-08 02:30
2913
Week's Top Stories
Most Reposted
NOVVA Group acquires 120 MWp Philippines solar project, anchoring its AI-era power platform in Southeast Asia
[Picked up by 302 media titles]
2026-06-19 11:12
Affinidi and CardInfoLink Put the Missing Trust Layer for AI Agents into Production
[Picked up by 301 media titles]
2026-06-19 09:00
Vietnam Explores Sustainable Aviation Fuel Development at International Conference in Hanoi
[Picked up by 301 media titles]
2026-06-25 14:33
IPD and ABB Help Power Sustainable Operations at New Sydney Fish Market
[Picked up by 298 media titles]
2026-06-22 17:40
SPHERE AX Partners with U.S. AI Semiconductor Company Blaize at the National Assembly
[Picked up by 292 media titles]
2026-06-24 18:00
Most Read
Resilience Actions, a Re Sustainability Initiative, Launches ECOHUB.IN to Power India's Climate and Circular Economy Innovation Ecosystem
2026-06-19 19:33
6198
LEIFRAS Co., Ltd. Reports Financial Results for the First Quarter of Fiscal Year 2026
2026-06-19 04:00
5666
